WHY VIRAL INFECTION LIMITS EFFECTIVENESS OF ANTI-ASTHMA DRUGS
Grant number: 1059665 | Funding period: 2014 - 2016
Chronic inflammatory lung diseases like asthma and smokers lung are treated with combinations of anti-inflammatory drugs. Powerful anti-inflammatory types of steroid drugs are used in more severe disease. Even these powerful drugs are sometimes not effective enough. Our work is developing an understanding of how inflammation limits the anti-inflammatory effects of steroids and we are devising ways to overcome this with new drugs. We aim to improve treatment of chronic inflammatory diseases, especially those affecting the lung.
Related publications (2)
Casein Kinase 1 delta/epsilon Inhibitor, PF670462 Attenuates the Fibrogenic Effects of Transforming Growth Factor-beta in Pulmonary Fibrosis
Christine R Keenan, Shenna Y Langenbach, Fernando Jativa, Trudi Harris, Meina Li, Qianyu Chen, Yuxiu Xia, Bryan Gao, Michael J Schuliga, Jade Jaffar, Danica Prodanovic, Yan Tu, Asres Berhan, Peter VS Lee, Glen P Westall, Alastair G Stewart
Transforming growth factor-beta (TGF-β) is a major mediator of fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). H..
Bronchial epithelial cells are rendered insensitive to glucocorticoid transactivation by transforming growth factor-beta 1
Christine R Keenan, Josephine SL Mok, Trudi Harris, Yuxiu Xia, Saad Salem, Alastair G Stewart
BACKGROUND: We have previously shown that transforming growth factor-beta (TGF-beta) impairs glucocorticoid (GC) function in pulmo..